Private weight loss injections in Leeds: what the evidence shows

What the clinical trials actually found, and why the numbers need context

The results from the pivotal trials are striking, and they deserve an honest read rather than a headline. In the STEP 1 trial, published in the New England Journal of Medicine, adults with obesity who used semaglutide 2.4mg weekly for 68 weeks alongside lifestyle changes lost an average of about 15% of their body weight. The tirzepatide programme (SURMOUNT-1, 72 weeks) produced average losses of around 20–21% at the highest dose across thousands of participants.

Those are averages. Some people lose more; some lose less. Trial participants also followed structured diet and activity programmes alongside the medicine, something every prescriber will discuss with you, because the injection is one part of a wider approach, not a replacement for it. A common misconception is that these medicines do the work independently of lifestyle. They reduce appetite considerably, which makes dietary change easier; they do not override it entirely.

For Leeds residents weighing up their options, the trials give a reasonable expectation of direction and scale, but your individual result will depend on your starting weight, the dose you reach, how long you stay on treatment and the lifestyle support you put around it. The NICE appraisal of tirzepatide (NICE TA1026) describes this evidence base in detail and underpins the current NHS eligibility criteria.

How NHS access works in Leeds, and where the gaps are

Mounjaro became available through some GP practices in England from April 2026 under a new GP contract, and NHS England has been rolling out phased eligibility based on BMI and specific health conditions. Currently, the NHS pathway covers adults with a BMI of 40 or above alongside four or more qualifying conditions from a defined list, high blood pressure, dyslipidaemia, obstructive sleep apnoea, cardiovascular disease and type 2 diabetes. A second cohort, covering BMI 35–39.9 with four or more of those conditions, opened in June 2026.

In practice, GP participation in the new contract is optional, so whether this is available at your practice in Leeds depends on the individual surgery. Wegovy (semaglutide) on the NHS routes through specialist weight management services under NICE TA875, where waiting lists in many areas stretch to months or longer. You can read more about how the NHS side works on our NHS weight loss injections page.

For people who do not meet the NHS thresholds, or who do not want to wait, private treatment through a registered pharmacy is the alternative. The clinical standards (prescriber review, identity checks, genuine licensed supply) apply equally whether you are seen privately or through the NHS. The key is choosing a provider that meets those standards.

What private access in Leeds actually looks like

A private prescription for a weight loss injection in Leeds can come from an in-person clinic or from a GPhC-registered online pharmacy that employs Independent Prescribers. The clinical process is the same either way: you complete a health assessment, a prescriber reviews it personally, and if you are suitable they issue a prescription. What differs is speed, cost structure and convenience.

Local weight loss injection clinics in Leeds offer face-to-face consultation, which some people prefer, and you can find a fuller breakdown of what to expect from that route on our private clinic weight loss injections page. Online services, including nume, remove the need to travel and typically move faster, our prescribers review consultations the same day, and treatment is dispatched the same day if approved, arriving free the next working day by tracked delivery. There are no hidden fees: one price covers the consultation, prescription, medicine and aftercare. You can explore what that looks like on the private weight loss injections near you page.

One thing worth knowing: genuine private treatment is priced per month by dose, and legitimate costs reflect the cost of the medicine, the clinical review and the pharmacy service. If you come across a supplier offering these medicines at prices far below what regulated pharmacies charge, or without any mention of a prescriber, that is a meaningful red flag. The MHRA has warned publicly about counterfeit and illegally traded weight loss pens, and the consequences of using unverified products can be serious. You can verify any online pharmacy on the GPhC register; nume's registration number is 9012878.

Starting treatment: eligibility and what the consultation covers

The private licensed criteria are broader than the NHS ones. Adults with a BMI of 30 or above, or 27 or above with at least one weight-related condition such as high blood pressure, raised cholesterol or prediabetes, may be eligible. Lower BMI thresholds apply for some ethnic backgrounds under UK guidance. The consultation is not a box-ticking exercise; a prescriber looks at your full health picture, your medicines, your history and your goals.

Our clinical team includes GPhC-registered Independent Prescribers who read every consultation personally. If you have questions before you start, our FAQs page covers the most common ones, and our team is available seven days a week for aftercare once you are on treatment. There is a broader overview of what to expect on the weight loss treatments overview page. When you are ready to take the next step, speaking to our prescribers is the place to start.

Speak to our prescribers, start your free consultation.